Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced positive topline results from its Phase 3 Casppian clinical trial evaluating the efficacy and safety of FP-001 42 mg (leuprolide ...
Security researchers have warned the users about the increasing risk of prompt injection attacks in the AI browsers.
“Prompt injection, much like scams and social engineering on the web, is unlikely to ever be fully ‘solved,'” OpenAI wrote in ...
OpenAI has deployed a new automated security testing system for ChatGPT Atlas, but has also conceded that prompt injection ...
Wegovy pill showed a mean weight loss of 16.6% in the OASIS 4 trial1Wegovy pill is indicated to reduce excess body weight and maintain weight reduction long-term and to reduce the risk of major advers ...
Clara Matos discusses the journey of shipping AI-powered healthcare products at Sword Health. She explains how to implement ...
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study ...
Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...
Microsoft says "Windows is evolving to empower people to use AI easily, securely & confidently," but users are upset.
Lyft has rearchitected its machine learning platform LyftLearn into a hybrid system, moving offline workloads to AWS ...
Hyderabad: A week after two men were found dead in an auto in a suspected drug overdose case on the Chandrayanguttamain road, police arrested five people, including a doctor and a student assistant, ...
Cobenfy is currently approved for the treatment of schizophrenia in adults. Cobenfy represents the first new pharmacological approach to treating schizophrenia in decades. The initial uptake is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback